Researchers Trace Glioma Brain Tumor Origins To Epigenome

2023-07-31 02:09:14

(MENAFN- Investor Brand Network) Estimates from the American Cancer Society show that doctors will diagnose around
24,000 malignant spinal cord or brain tumors
this year, with an estimated 18,990 people losing their lives to the condition.

Gliomas are a class of tumors that grow on the brain or spinal cord, applying pressure onto crucial parts of the brain and causing symptoms such as...

NOTE TO INVESTORS:
The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company's newsroom at

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via
investorwire
to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with
bmw prime . As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text“Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:

BioMedWire (BMW)
San Francisco, California

415.949.5050 Office

BioMedWire is part of the
investorbrandnetwork .

MENAFN31072023000224011066ID1106754530

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.